Evidence is accumulating that analyzing cell-free DNA and/or samples from circulating tumor cells provides a good surrogate for bone marrow in these patients.
The company hopes to replicate its early data in future studies, making a case that better early diagnosis can improve outcomes for patients with schizophrenia and bipolar disorder.
The company hopes to replicate its early data in future studies, making a case that better early diagnosis can improve outcomes for patients with schizophrenia and bipolar disorder.
Critics worry that without appropriate safeguards, DNA phenotyping will lead to discrimination while supporters see it as a tool to help investigate crimes.
NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.
The BD Rhapsody Single-Cell Analysis System empowers and streamlines single-cell research with a complete system of tools, including reagents and analysis software, that work together to meet neuroscience experimental needs. Neuroscientists’ ability to identify and characterize individual cells in the nervous system opens the door to finding pathogenic cells, regenerative cells, and pathways that drug manufacturers can exploit for the discovery of therapeutics for neurodegenerative disease.
As the field of therapeutic antibody research expands, scientists face a growing need for software that enables them to efficiently and accurately analyze their data. Highly functional bioinformatics software solutions significantly reduce the need to manually curate sequence data or convert it into different formats for sharing and archiving. Unfortunately, there are currently few specialist antibody screening and analysis platforms that can be quickly configured to meet the highly custom needs of specialized therapeutic antibody discovery organizations.
Highly predictive patient-derived xenograft (PDX) models can predict clinical efficacy for oncology drug candidates better than traditional cell line-derived preclinical models. This white paper describes how PDX models can be used in Mouse Clinical Trials, upending the traditional paradigm in animal studies and providing a better perspective of patient-to-patient heterogeneity.
